Trade with Eva: Analytics in action >>

Wednesday, February 13, 2019

-=Natus Medical (BABY) reported earnings on Wed 13 Feb 2019 (b/o)

Founded: 1987
Headquarters: Pleasanton, CA
natus.com

Natus Medical misses by $0.06, beats on revs; guides Q1 EPS below two analyst estimate, revs below two analyst estimate; guides FY19 EPS below two analyst estimate, revs below two analyst estimate
  • Reports Q4 (Dec) earnings of $0.43 per share, excluding non-recurring items, $0.06 worse than the two analyst estimate of $0.49; revenues rose 7.3% year/year to $141 mln vs the $135.8 mln two analyst estimate.
  • Co issues downside guidance for Q1, sees EPS of $0.01-0.08, excluding non-recurring items, vs. $0.28 two analyst estimate; sees Q1 revs of $111-115 mln vs. $129.30 mln two analyst estimate.
  • Co issues downside guidance for FY19, sees EPS of $1.12-1.49, excluding non-recurring items, vs. $1.64 two analyst estimate; sees FY19 revs of $490-510 mln vs. $528.15 mln two analyst estimate.
  • Co also announced a significant refreshment of its board of directors with the appointment of Alice D. Schroeder, former CEO and Chair of WebTuner Corporation and Thomas J. Sullivan, President and CEO of A&E Medical Corporation to its board of directors effective February 11, 2019. The company will also nominate Ms. Schroeder and Mr. Sullivan for election at Natus' 2019 Annual Meeting of Stockholders.

No comments:

Post a Comment